Evidence map›Paper›PMID 42179218›Full record

ReviewAngewandte Chemie (International ed. in English)2026

Electroenzymatic CO

Leonardo Castañeda-Losada, Michael Richter, Christophe Léger, Vincent Fourmond, Nicolas Plumeré

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Semiartificial COChemical reviews · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leonardo Castañeda-LosadaFraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Bio-, Chemo- and Electrocatalysis BioCat, Straubing, Germany.ORCID https://orcid.org/0000-0003-2197-8764
Michael RichterFraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Bio-, Chemo- and Electrocatalysis BioCat, Straubing, Germany.ORCID https://orcid.org/0000-0002-7661-2973
Christophe LégerCNRS, Aix Marseille Univ, BIP, Marseille, France.ORCID https://orcid.org/0000-0002-8871-6059
Vincent FourmondCNRS, Aix Marseille Univ, BIP, Marseille, France.ORCID https://orcid.org/0000-0001-9837-6214
Nicolas PlumeréCampus Straubing for Biotechnology and Sustainability, Technical University of Munich (TUM), Straubing, Bayern, Germany.ORCID https://orcid.org/0000-0002-5303-7865

Funding

ANRBMBF project 031B1405ABMBF project ECO2DIS 031B1405DDFG 490864939/ANR-21-21-CE50-0041DFG ANR-22-PESP-0010DFG ANR-23-44CE-0046DFG ANR-23-SODR-0004DFG Projet ciblé "POWERCO2"DFG SPLEENEuropean Innovation Council 101115403European Innovation Council 101219355
6 · The paper itself

Abstract

Replacing fossil resources with renewable alternatives for chemical production requires highly integrated, energy-efficient, and selective CO

Indexed as

aerobic stabilitycatalytic reversibilitycofactor regenerationconfinementelectron mediation

Identifiers

PMID42179218
PMCPMC13340500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.